Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
作者： Ole Jakob Storebø , Nadia Pedersen , Erica Ramstad , Maja Laerke Kielsholm , Signe Sofie Nielsen
DOI: 10.1002/14651858.CD012069.PUB2
关键词: Meta-analysis 、 Methylphenidate 、 Attention deficit hyperactivity disorder 、 Clinical trial 、 Medicine 、 Relative risk 、 Internal medicine 、 Adverse effect 、 Cohort study 、 Young adult
摘要: … cross‐sectional studies of methylphenidate administered at any dosage or formulation. We also included methylphenidate groups from RCTs assessing methylphenidate versus other …
core.ac.uk
cochrane.ir参考文章(651)
John S March, James M Swanson, L Eugene Arnold, Betsy Hoza, C Keith Conners, Stephen P Hinshaw, Lily Hechtman, Helena C Kraemer, Laurence L Greenhill, Howard B Abikoff, L Glen Elliott, Peter S Jensen, Jeffrey H Newcorn, Benedetto Vitiello, Joanne Severe, Karen C Wells, William E Pelham, None, Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). Journal of Abnormal Child Psychology. ,vol. 28, pp. 527- 541 ,(2000) , 10.1023/A:1005179014321
Fatih Hilmi ÇETİN, Yasemin TAŞ TORUN, Yasemen IŞIK TANER, Atomoxetine Versus Oros Methylphenidate in Attention Deficit Hyperactivity Disorder: A Six-Month Follow Up Study for Efficacy and Adverse Effects Turkiye Klinikleri Tip Bilimleri Dergisi. ,vol. 35, pp. 88- 96 ,(2015) , 10.5336/MEDSCI.2015-43336
William E. Pelham Jr., Elizabeth M. Gnagy, Andrew R. Greiner, Betsy Hoza, Stephen P. Hinshaw, James M. Swanson, Steve Simpson, Cheri Shapiro, Oscar Bukstein, Carrie Baron-Myak, Keith McBurnett, Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. Journal of Abnormal Child Psychology. ,vol. 28, pp. 507- 525 ,(2000) , 10.1023/A:1005127030251
Nilamadhab Kar, Baikunthanath Misra, Toxoplasma seropositivity and depression: a case report BMC Psychiatry. ,vol. 4, pp. 1- 2 ,(2004) , 10.1186/1471-244X-4-1
Shahin Akhondzadeh, Mohammad-Reza Mohammadi, Mojgan Khademi, Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371] BMC Psychiatry. ,vol. 4, pp. 9- 9 ,(2004) , 10.1186/1471-244X-4-9
Jasmin Garg, Priti Arun, BS Chavan, Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder. International Journal of Applied and Basic Medical Research. ,vol. 5, pp. 114- ,(2015) , 10.4103/2229-516X.157162
Samuele Cortese, Pietro Panei, Romano Arcieri, Elena A. P. Germinario, Annalisa Capuano, Lucia Margari, Flavia Chiarotti, Paolo Curatolo, Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry CNS Drugs. ,vol. 29, pp. 865- 877 ,(2015) , 10.1007/S40263-015-0266-7
Joseph Biederman, Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD. The Journal of Clinical Psychiatry. ,vol. 64, pp. 3- 8 ,(2003)
Kouichi Yoshimasu, William J. Barbaresi, Robert C. Colligan, Robert G. Voigt, Jill M. Killian, Amy L. Weaver, Slavica K. Katusic, Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study Journal of Child Psychology and Psychiatry. ,vol. 53, pp. 1036- 1043 ,(2012) , 10.1111/J.1469-7610.2012.02567.X
Andreas Lundh, Joel Lexchin, Barbara Mintzes, Jeppe B Schroll, Lisa Bero, None, Industry sponsorship and research outcome Cochrane Database of Systematic Reviews. ,vol. 2, pp. 0- 0 ,(2017) , 10.1002/14651858.MR000033.PUB3